A Study of RMC-5127 in People With Solid Tumor Cancer

Full Title

Phase 1/1b, Multicenter, Open-Label, Study of RMC-5127 in Patients with Advanced KRAS G12V-Mutant Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Wungki Park’s office at 646-888-4543.

Protocol
26-220
Phase
Phase I (phase 1)
Investigator
Wungki Park
Co-Investigators
Kathryn C. Arbour
Eileen M. O'Reilly
Rona Yaeger
Diseases
Colorectal Cancer
Hepatobiliary › Pancreatic Cancer
Lung Cancer › Lung Cancer, Non-Small Cell
Solid Tumors
Upper Gastrointestinal › Pancreatic Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07349537
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description